News

Landos, founded by serial entrepreneur and innovator Dr. Josep Bassaganya-Riera, is advancing a robust pharmaceutical pipeline for autoimmune diseases toward commercialization and will partner operational efforts with Xontogeny,

In conjunction with this achievement, Eleven is ending its large-scale manufacturing activities and redirecting resources toward completing its Phase 3 trial and preparing for discussions with the U.S.

The two companies have entered into a clinical research collaboration in this regard to assess the therapeutic regimen in NSCLC and potentially other advanced solid tumors in the

Non-inferiority versus daily growth hormone was not demonstrated in the intent to treat (ITT) population for the primary efficacy variable, height velocity (HV) at 12 months. The 12-month

Bavencio, which is intended to be delivered intravenously, is a human antibody designed to inhibit the programmed death ligand-1 (PD-L1) protein. It has been developed to potentially engage

Gazyvaro is an engineered monoclonal antibody proposed to attach to CD20, a protein expressed on certain B cells, but not on stem cells or plasma cells. It is

Located in Shanghai, China, the center will provide a full range of process development capabilities and services, including cell line development, upstream and downstream process development and non-GMP

Movement disorders like Essential Tremor are associated with abnormal activity of the brain’s neural networks. T-type calcium channels, called Cav3, control the firing and signaling between neurons. CX-8998

Acoustic liquid dispensing, pioneered by Labcyte, uses the gentle energy of sound waves to move minute quantities of liquid with precision and accuracy. It has been enhanced to